skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index

Koroner Kalp Hastalarında PCSK9 E670G ve N425S Gen Varyasyonlarının Etkisinin Türk Toplumunda Değerlendirilmesi

İstanbul gelişim üniversitesi sağlık bilimleri dergisi : (Online), 2018-04 (4), p.345 [Peer Reviewed Journal]

2018. This work is published under https://creativecommons.org/licenses/by-nc-nd/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 2536-4499 ;EISSN: 2602-2605

Full text available

Citations Cited by
  • Title:
    Koroner Kalp Hastalarında PCSK9 E670G ve N425S Gen Varyasyonlarının Etkisinin Türk Toplumunda Değerlendirilmesi
  • Author: Ayşegül Başak AKADAM TEKER ; TEKER, Erhan ; Özlem KURNAZ GÖMLEKSİZ ; Hülya YILMAZ AYDOĞAN
  • Subjects: Atherosclerosis ; Cardiovascular disease ; Cholesterol ; Genetics ; Lipoproteins
  • Is Part Of: İstanbul gelişim üniversitesi sağlık bilimleri dergisi : (Online), 2018-04 (4), p.345
  • Description: Aim: Coronary artery disease (CAD) due to atherosclerosis is a multifactorial disease resulting from the interaction of numerous genetic and environmental factors. In developed countries, it is among the diseases with highest rates of mortality and morbidity. Proprotein convertase subtilisin/kexin 9 (PCSK9), plays an important role for cholesterol homoeostasis via inducing post-transcriptional degradation of Low-density lipoprotein-Receptor (LDLR).Since PCSK9’s first discovery in 2003, studies focusing on PCSK9 continue without slowing down and now PCSK9 is a candidate as a new therapeutic target in atherosclerosis. However, little is known about the genetic variants of PCSK9 and its influence on Low Density Lipoprotein – cholesterol (LDL-C) in Turkish population. Mutations in the PCSK9 gene have been associated with both hypocholesterolemia and hypercholesterolemia through ‘loss-of-function’ and ‘gain-of-function’ mechanisms, respectively. Our aim was to investigate PCSK9 N425S (rs28362261) and E670G (23968A>G) (rs 505151) gene polymorphisms in regard to their effects on serum lipoprotein level and development of CHD. Method: PCR-RFLP (Polymerase Chain Reaction-Restriction Fragment Length Polymorphism) method is used for determination of PCSK9 variants. Findings: In the patient group, frequency of PCSK9 E670G mutant T allele is higher than controls. Our findings indicate that these variants might be an independent risk factors in development of CHD. In the patient group, we observed the PCSK9 E670G normal A allele is associated with increased serum total-cholesterol level. Conclusion: In conclusion we suggest that the PCSK9 gene variants might pose a risk in susceptibility to CHD, since PCSK9 has detrimental effects on serum lipids.
  • Publisher: Istanbul: Istanbul Gelisim University
  • Language: English;Turkish
  • Identifier: ISSN: 2536-4499
    EISSN: 2602-2605
  • Source: ProQuest Central
Back to results list
INSPIRE LIBRARY - TON DUC THANG UNIVERSITY (84-028) 37 755 057 Feedback
19 Nguyen Huu Tho St. Dist.7, HCM thuvien@tdtu.edu.vn

Copyright © 2017 INSPIRE LIBRARY - TON DUC THANG UNIVERSITY

Searching Remote Databases, Please Wait